ÂÜÀòÂÒÂ×

Reto Senn is an accomplished executive with extensive experience in the medical technology and healthcare sectors. Currently serving as a Board Member at machineMD and Chairperson of the Board at Von Hoff AG, Reto has demonstrated expertise in business development, commercialization, and strategic marketing. As CEO of nucleoptis International since March 2021, Reto focuses on investments within the med tech sector, particularly in eye care. Previous roles include Executive Vice President at AddVision, VP of Business Development and Licensing at Zuellig Pharma, and Regional Director for Parazelsus in Asia. Reto's career highlights include driving significant growth, overseeing P&L responsibilities, and executing successful business acquisitions across various regions. Reto Senn holds a Master of Arts in Economics from the University of St.Gallen and a Master's degree from the University of Zurich.